Related Experiment Video
Updated: Dec 24, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart
A Mantovani1, G Lunardi2, S Bonapace3
1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy.
Insights
Plasma ceramide levels are elevated in patients with chronic kidney disease (CKD). These findings hold true even when accounting for heart disease and diabetes, suggesting ceramides as potential biomarkers for CKD.
Area of Science:
- Biochemistry
- Nephrology
- Cardiology
Background:
- Plasma ceramides are elevated in patients with ischemic heart disease (IHD).
- The relationship between plasma ceramides and chronic kidney disease (CKD) is not well-established.
- Shared risk factors exist for IHD and CKD.
Purpose of the Study:
- To investigate whether plasma ceramide levels are increased in patients with CKD.
- To determine the association between plasma ceramides and CKD, independent of other cardiovascular risk factors.
Main Methods:
- Measured six specific plasma ceramide concentrations in 415 middle-aged individuals.
- Defined CKD based on estimated glomerular filtration rate (e-GFR) and urinary albumin-to-creatinine ratio.
- Analyzed associations after adjusting for multiple cardiovascular risk factors.
Main Results:
- Patients with CKD exhibited significantly higher levels of all six measured plasma ceramides compared to those without CKD.
- CKD remained significantly associated with elevated plasma ceramides after adjusting for BMI, smoking, hypertension, diabetes, IHD, LDL-cholesterol, hs-CRP, and lipid-lowering medication use.
- Advanced CKD stages and abnormal albuminuria were independently associated with increased plasma ceramide levels.
Conclusions:
- Elevated plasma ceramide levels are associated with CKD.
- This association is independent of pre-existing IHD, diabetes, and other established cardiovascular risk factors.
- Plasma ceramides may serve as potential biomarkers for CKD.
Aim:
Plasma levels of certain ceramides are increased in patients with ischemic heart disease (IHD). Many risk factors for IHD are also risk factors for chronic kidney disease (CKD), but it is currently uncertain whether plasma ceramide levels are increased in patients with CKD.
Methods:
We measured six previously identified high-risk plasma ceramide concentrations [Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0) and Cer(d18:1/24:1)] in 415 middle-aged individuals who attended our clinical Cardiology and Diabetes services over a period of 9 months.
Results:
A total of 97 patients had CKD (defined as e-GFRCKD-EPI<60ml/min/1.73m2 and/or urinary albumin-to-creatinine ratio≥30mg/g), 117 had established IHD and 242 had type 2 diabetes. Patients with CKD had significantly (P=0.005 or less) higher levels of plasma Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0), and Cer(d18:1/24:1) compared to those without CKD. The presence of CKD remained significantly associated with higher levels of plasma ceramides (standardized beta coefficients ranging from 0.124 to 0.227, P<0.001) even after adjustment for body mass index, smoking, hypertension, diabetes, prior IHD, plasma LDL-cholesterol, hs-C-reactive protein levels and use of any lipid-lowering medications. Notably, more advanced stages of CKD and abnormal albuminuria were both associated (independently of each other) with increased levels of plasma ceramides. These results were consistent in all subgroups considered, including patients with and without established IHD or those with and without diabetes.
Conclusion:
Increased levels of plasma ceramides are associated with CKD independently of pre-existing IHD, diabetes and other established cardiovascular risk factors.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

